Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
- Conditions
- FrailtyCognitive ImpairmentCKD Stage 5CKD Stage 4
- Registration Number
- NCT05705011
- Lead Sponsor
- Grigore T. Popa University of Medicine and Pharmacy
- Brief Summary
This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease \].
The main question\[s\] it aims to answer are:
* What determines the time to initiate dialysis? Cognitive impairment or frailty?
* What does predict the time to death? Presence of frailty or cognitive impairment?
* What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 240
- Patients age 65 years or older.
- CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2 separated by more than 3 months.
- Patients younger than 65 years old.
- Chronic kidney disease stages 1,2, and 3.
- Dialysis dependence
- History of kidney transplantation.
- Initial visit with the health care provider.
- Recent acute kidney injury.
- Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)
- Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment
- Patients who are blind or with limb amputation.
- Patients who refuse to participate.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to initiate dialysis. 36 months The time from the assessment moment to start dialysis of an older adult with advanced CKD (
Time to death 36 months The time from the assessment moment to death of an older adult with advanced CKD ( CKD stage 4 and 5).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Medicine and Pharmacy "Grigore T. Popa"
🇷🇴Iasi, Romania